Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

The secrets of the pharmaceutical launch A-team

A new report reveals all

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Innovative Trials

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Innovative Trials

- PMLiVE

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

Innovative Trials

- PMLiVE

Recognizing C diff Awareness Month in 2024

Every year, the medical community recognizes the month of November as Clostridioides difficile (C. diff) Awareness month. C. diff is a public health threat that causes around 500,000 infections every...

Medscape Education

- PMLiVE

AbbVie to expand neuroscience pipeline with $1.4bn Aliada Therapeutics acquisition

The deal includes a candidate in phase 1 development for Alzheimer's disease

- PMLiVE

UK life sciences sector responds to Labour government’s Autumn Budget

Key measures include a £520m life sciences innovative manufacturing fund

- PMLiVE

Johnson & Johnson’s Tremfya shows promise in ‘special site’ plaque psoriasis

The immune-mediated disease affects more than 125 million people worldwide

- PMLiVE

Delivering inclusive events

When talking about diversity and inclusion, we also need to consider those disabilities that are not visible

Generative AI platforms drive drug discovery dealmaking

AI-Driven Platforms Enhance Drug Discovery Collaborations

Generative AI platforms are revolutionizing drug discovery, driving significant biopharma dealmaking by enabling the design of innovative small-molecule and biologic drug candidates.

Springer Nature

- PMLiVE

Medscape Education presenting at the 17th Annual European CME Forum

With a commitment to advancing the field of continuing medical education, the Medscape team will be travelling to Madrid for the 17th Annual European CME Forum and bringing with them...

Medscape Education

- PMLiVE

Pfizer’s Elrexfio recommended by NICE to treat relapsed and refractory multiple myeloma

Approximately 5,000 people are diagnosed with the disease every year in England

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links